Jiaqi Zhang - DV Biomed Director

6539 Stock  TWD 66.80  0.20  0.30%   

Insider

Jiaqi Zhang is Director of DV Biomed Co since 2013.
Tenure 11 years
Phone886 2 2791 1826
Webhttp://www.dvbiomed.com

DV Biomed Management Efficiency

The company has return on total asset (ROA) of 8.85 % which means that it generated a profit of $8.85 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 23.52 %, meaning that it generated $23.52 on every $100 dollars invested by stockholders. DV Biomed's management efficiency ratios could be used to measure how well DV Biomed manages its routine affairs as well as how well it operates its assets and liabilities.
DV Biomed Co has accumulated 249.93 M in total debt with debt to equity ratio (D/E) of 0.21, which may suggest the company is not taking enough advantage from borrowing. DV Biomed has a current ratio of 2.27, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DV Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, DV Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DV Biomed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for 6539 to invest in growth at high rates of return. When we think about DV Biomed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 11 records

INSIDER Age

Li HeFanHung Sheng Construction
N/A
ShuChen ChiangFarGlory Hotel Co
N/A
Shu LinFarGlory Hotel Co
N/A
YungFu LuHung Sheng Construction
N/A
HanLin LiFarGlory Hotel Co
N/A
YuTe ChenHung Sheng Construction
N/A
Chih WangHung Sheng Construction
N/A
Shi DongRuentex Engineering Constructio
N/A
Ruizhen WangRuentex Engineering Constructio
N/A
Shi ZhengFarGlory Hotel Co
N/A
ChunHsien ChangFarGlory Hotel Co
N/A
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. DV Biomed Co (6539) is traded on Taiwan OTC Exchange in Taiwan and employs 316 people.

Management Performance

DV Biomed Leadership Team

Elected by the shareholders, the DV Biomed's board of directors comprises two types of representatives: DV Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 6539. The board's role is to monitor DV Biomed's management team and ensure that shareholders' interests are well served. DV Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DV Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Qunzhi Chen, Independent Director
Peter Hou, Independent Director
Xiumei Xie, Chief Financial Officer, Head of Finance
Liqi Zhang, Chairman of the Board, General Manager
RongChun Lin, Independent Director
Senxiong Zhang, Independent Director
Qingjun Huang, Deputy General Manager-Administration Division
Mingtong Chen, Director
Jiaqi Zhang, Director
Mingfeng He, Head of Finance & Accounting
Yiyun Li, Chief Operating Officer

6539 Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DV Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with DV Biomed

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DV Biomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will appreciate offsetting losses from the drop in the long position's value.

Moving together with 6539 Stock

  0.644114 Synmosa BiopharmaPairCorr
  0.656620 Handa PharmaceuticalsPairCorr

Moving against 6539 Stock

  0.672881B Fubon Financial HoldingPairCorr
  0.669904 Pou Chen CorpPairCorr
  0.62881A Fubon Financial HoldingPairCorr
  0.552882B Cathay Financial HoldingPairCorr
  0.540057 Fubon MSCI TaiwanPairCorr
The ability to find closely correlated positions to DV Biomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DV Biomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DV Biomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DV Biomed Co to buy it.
The correlation of DV Biomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DV Biomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DV Biomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DV Biomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for 6539 Stock Analysis

When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.